X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare PLETHICO PHARMA with GSK Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs GSK PHARMA - Comparison Results

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA GSK PHARMA PLETHICO PHARMA/
GSK PHARMA
 
P/E (TTM) x -1.1 60.0 - View Chart
P/BV x 0.0 11.8 0.1% View Chart
Dividend Yield % 0.0 2.1 -  

Financials

 PLETHICO PHARMA   GSK PHARMA
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
GSK PHARMA
Mar-16
PLETHICO PHARMA/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs3953,850 10.3%   
Low Rs312,966 1.1%   
Sales per share (Unadj.) Rs604.4332.3 181.9%  
Earnings per share (Unadj.) Rs32.544.3 73.3%  
Cash flow per share (Unadj.) Rs51.347.2 108.7%  
Dividends per share (Unadj.) Rs050.00 0.0%  
Dividend yield (eoy) %01.5 0.0%  
Book value per share (Unadj.) Rs473.6202.7 233.6%  
Shares outstanding (eoy) m34.0884.70 40.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.410.3 3.4%   
Avg P/E ratio x6.676.9 8.5%  
P/CF ratio (eoy) x4.272.2 5.8%  
Price / Book Value ratio x0.516.8 2.7%  
Dividend payout %0112.9 0.0%   
Avg Mkt Cap Rs m7,262288,643 2.5%   
No. of employees `000NA4.6 0.0%   
Total wages/salary Rs m1,5964,434 36.0%   
Avg. sales/employee Rs ThNM6,104.5-  
Avg. wages/employee Rs ThNM961.6-  
Avg. net profit/employee Rs ThNM813.7-  
INCOME DATA
Net Sales Rs m20,59828,148 73.2%  
Other income Rs m3861,218 31.7%   
Total revenues Rs m20,98429,366 71.5%   
Gross profit Rs m2,8184,774 59.0%  
Depreciation Rs m642248 259.0%   
Interest Rs m1,5930-   
Profit before tax Rs m9695,744 16.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m026 0.0%   
Tax Rs m-1382,018 -6.9%   
Profit after tax Rs m1,1073,752 29.5%  
Gross profit margin %13.717.0 80.7%  
Effective tax rate %-14.335.1 -40.7%   
Net profit margin %5.413.3 40.3%  
BALANCE SHEET DATA
Current assets Rs m18,87721,462 88.0%   
Current liabilities Rs m11,89610,536 112.9%   
Net working cap to sales %33.938.8 87.3%  
Current ratio x1.62.0 77.9%  
Inventory Days Days3668 53.1%  
Debtors Days Days19816 1,205.0%  
Net fixed assets Rs m9,8614,717 209.0%   
Share capital Rs m341847 40.2%   
"Free" reserves Rs m12,33116,308 75.6%   
Net worth Rs m16,13917,171 94.0%   
Long term debt Rs m4,70616 29,411.3%   
Total assets Rs m33,14630,620 108.2%  
Interest coverage x1.6NM-  
Debt to equity ratio x0.30 31,293.5%  
Sales to assets ratio x0.60.9 67.6%   
Return on assets %8.112.3 66.5%  
Return on equity %6.921.9 31.4%  
Return on capital %12.333.6 36.6%  
Exports to sales %21.40 150,401.4%   
Imports to sales %15.215.1 101.1%   
Exports (fob) Rs m4,4024 110,060.0%   
Imports (cif) Rs m3,1364,237 74.0%   
Fx inflow Rs m4,402519 848.2%   
Fx outflow Rs m3,1848,320 38.3%   
Net fx Rs m1,219-7,801 -15.6%   
CASH FLOW
From Operations Rs m2,4371,386 175.9%  
From Investments Rs m-6,2655,010 -125.1%  
From Financial Activity Rs m2,490-6,383 -39.0%  
Net Cashflow Rs m-1,33712 -11,331.9%  

Share Holding

Indian Promoters % 82.7 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 4.3 10.2 42.2%  
FIIs % 5.5 23.8 23.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 7.5 15.4 48.7%  
Shareholders   10,665 102,036 10.5%  
Pledged promoter(s) holding % 85.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   ALKEM LABORATORIES  FRESENIUS KABI ONCO.  GLENMARK PHARMA  TORRENT PHARMA  STRIDES SHASUN LTD  

Compare PLETHICO PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA 8-QTR ANALYSIS

COMPARE PLETHICO PHARMA WITH

MARKET STATS